CoreLine Soft Co

CoreLine Soft Co EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of CoreLine Soft Co (384470.KQ) as of Nov 11, 2026 is -13.28 B KRW. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was -10.88 B KRW — a change of 22.06% (lower).

EBITDA

-13.28 BKRW

YoY

22.06%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of CoreLine Soft Co is 2024 -13.28 B KRW. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of CoreLine Soft Co was 2023 -10.88 B KRW. It decreases by 22.06% lower compared to the previous year.

The CoreLine Soft Co EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2020
-3.14 B KRW
Jan 1, 2021
-6.93 B KRW
Jan 1, 2022
-9.40 B KRW
Jan 1, 2023
-10.88 B KRW
Jan 1, 2024
-13.28 B KRW
The CoreLine Soft Co EBITDA history
YEAREBITDAYoY
-13.28 BKRW+22.06%
-10.88 BKRW+15.73%
-9.40 BKRW+35.62%
-6.93 BKRW+121.15%
-3.14 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

CoreLine Soft Co Stock analysis

What does CoreLine Soft Co do? CoreLine Soft Co Ltd develops and supplies AI-based medical image analysis software for healthcare professionals. The company's main products analyze CT images of the chest, head, and neck to assist in diagnosis and support treatment and research. The firm targets medical staff in hospitals and research institutions who require advanced diagnostic tools. CoreLine Soft generates revenue through the sale of its medical software solutions to healthcare providers and research organizations. The company operates in the Health Care Technology industry with a focus on AI-driven medical imaging. CoreLine Soft's products are designed to enhance diagnostic accuracy and streamline treatment planning for medical professionals. Revenue is derived from licensing agreements with healthcare facilities and research entities that integrate the software into their diagnostic workflows. CoreLine Soft Co Ltd is a Korea-based company headquartered in Seoul. The firm's primary business model revolves around the development and commercialization of AI-based medical software. The company's revenue streams come from direct sales of its CT image analysis solutions to hospitals and research institutions seeking to improve diagnostic efficiency and patient outcomes. CoreLine Soft Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about CoreLine Soft Co stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of CoreLine Soft Co is -13.28 B KRW in 2024.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of CoreLine Soft Co changed from -10.88 B KRW to -13.28 B KRW, representing a 22.06% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) CoreLine Soft Co since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s CoreLine Soft Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — CoreLine Soft Co

All Key Metrics — CoreLine Soft Co